Return to study ST000594 main page

Download data matrix(PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79) (part II) Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODEHQL_01Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_02Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_03Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_04Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_05Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_06Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_07Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEHQL_08Treatment:HQL-79pmol/g
Reversed phase NEGATIVE ION MODEVeh_01Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_02Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_03Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_04Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_05Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_06Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_07Treatment:Vehiclepmol/g
Reversed phase NEGATIVE ION MODEVeh_08Treatment:Vehiclepmol/g
  logo